May 10, 2022 Experience Bausch + Lomb $630 million IPO We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
May 3, 2022 Experience HilleVax $200 million IPO The shares are listed on the Nasdaq Global Select Market
April 27, 2022 Experience Acutus Medical sale of its left-heart access portfolio products We are advising Acutus Medical on the transaction
April 27, 2022 Experience Ingenovis Health acquisition of VISTA Staffing Solutions We are advising Ingenovis Health, Cornell Capital and Trilantic on the transaction
April 18, 2022 Experience Natus Medical $1.2 billion acquisition by ArchiMed We are advising Natus Medical on the transaction
April 6, 2022 Experience Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings We advised Charles River on the transaction
March 25, 2022 Experience AN2 Therapeutics $69 million IPO The shares are listed on the Nasdaq Global Select Market
February 11, 2022 Experience Signify Health $250 million acquisition of Caravan Health We are advising Signify Health on the transaction
January 20, 2022 Experience Silver Spike Acquisition Corp. II combination with Eleusis We are advising the SPAC on the transaction
January 19, 2022 Experience Smith+Nephew acquisition of Engage Surgical We are advising Smith+Nephew on the transaction